Cover Image

Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients

Abstract Apomorphine, used to treat OFF episodes in patients with Parkinson's disease (PD), is typically administered via subcutaneous injections. Administration of an oromucosal solution could offer a non‐invasive and user‐friendly alternative. This two‐part clinical study evaluated the safety...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eva Thijssen (Author), Bert Tuk (Author), Michel Cakici (Author), Veerle vanVelze (Author), Erica Klaassen (Author), Frans Merkus (Author), Teus vanLaar (Author), Philip Kremer (Author), Geert Jan Groeneveld (Author)
Format:	Book
Published:	Wiley, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson's disease
by: Felix Agbo, et al.
Published: (2021)

Investigation of apomorphine during sleep in Parkinson's: Improvement in UPDRS Scores
by: Miguel A. Pieroni
Published: (2019)

Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease
by: Nrupa Borkar, et al.
Published: (2018)

Oromucosal Administration of Interferon to Humans
by: Manfred W. Beilharz, et al.
Published: (2010)

Oromucosal Administration of Oxytocin: The Development of 'Oxipops'
by: Dan Xu, et al.
Published: (2024)

Apomorphine Targets the Pleiotropic Bacterial Regulator Hfq
by: Florian Turbant, et al.
Published: (2021)

Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis
by: Hiroshi Maeda, et al.
Published: (2024)

Stability of apomorphine in solutions containing selected antioxidant agents
by: Ang ZY, et al.
Published: (2016)

Prevention of medication errors in healthcare transition of patients treated with apomorphine
by: M. Ucha Sanmartin, et al.
Published: (2014)

Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
by: Daniela A. Rodrigues, et al.
Published: (2021)

Pullulan-Based Spray-Dried Mucoadhesive Microparticles for Sustained Oromucosal Drug Delivery
by: Ting Liu, et al.
Published: (2024)

Turmeric active substance, curcumin, enhanced apomorphine-induced yawning in rats
by: Esmaeal Tamaddonfard
Published: (2013)

Inhibitory Effect of Apomorphine on Focal and Nonfocal Plasticity in the Human Motor Cortex
by: Shane M. Fresnoza, et al.
Published: (2021)

Non-Targeted Metabolomics Reveal Apomorphine's Therapeutic Effects and Lysophospholipid Alterations in Steatohepatitis
by: Hideo Ogiso, et al.
Published: (2024)

Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson's disease
by: Marianne Luinstra, et al.
Published: (2019)

Evaluation of Oromucosal Natural Gum-Based Emulgels as Novel Strategy for Photodynamic Therapy of Oral Premalignant Lesions
by: Emilia Szymańska, et al.
Published: (2023)

Effect of nabiximols oromucosal spray (Sativex®) on symptoms associated with multiple sclerosis-related spasticity: a case series
by: Niklas Garde, et al.
Published: (2024)

Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic
by: Nadezhda Ivanova, et al.
Published: (2022)

A leucine‐rich repeat kinase 2 (LRRK2) pathway biomarker characterization study in patients with Parkinson's disease with and without LRRK2 mutations and healthy controls
by: Maurits F. J. M. Vissers, et al.
Published: (2023)

Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease Kinases, GTPases and ATPases
by: Veerle Baekelandt
Published: (2015)

First‐in‐human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS‐penetrant soluble guanylyl cyclase stimulator
by: Sebastiaan J. W. vanKraaij, et al.
Published: (2023)

An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland, who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray
by: Etges T, et al.
Published: (2016)

Parkinson's Disease
by: A. van Wieringen
Published: (1971)

Terminalia chebula 10% Mouth Rinse, Topical Curcumin Oral Gel and Topical 0.1% Triamcinolone Acetonide Oromucosal Paste in the Management of Oral Aphthous Ulcers - An Interventional Study
by: Arulraj Peterlouis, et al.
Published: (2024)

EL BOSTEZO INDUCIDO POR APOMORFINA EN RATAS ALCOHOLIZADAS EN PERIODO DE ABSTINENCIA: EVIDENCIAS DE UN MECANISMO DOPAMINERGICO POSTSINAPTICO The apomorphine induced yawning in rats
by: Alain Hernández Darias, et al.
Published: (2008)

A phase I, randomized, double‐blind, placebo‐controlled, single‐ and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX‐128, a highly selective Nav1.8 inhibitor, in healthy adults
by: Hemme J. Hijma, et al.
Published: (2022)

Clearing the smokescreen: The current evidence on cannabis use
by: Margriet van Laar
Published: (2015)

The effect of the quality of coronal restoration versus the quality of root canal filling on periapical health: systematic review and meta-analysis
by: Elif Bahar ÇAKICI, et al.
Published: (2022)

Priorities in healthcare provision in Parkinson's disease from the perspective of Parkinson Nurses: A focus group study
by: Marlena van Munster, et al.
Published: (2024)

Chapter Improving Argumentative Skills in Education: Three Online Discussion Tools
by: van Laar, Jan Albert
Published: (2021)

Chapter Improving Argumentative Skills in Education: Three Online Discussion Tools
by: van Laar, Jan Albert
Published: (2021)

Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer
by: Van Laar Ryan K
Published: (2012)

Analgesic drug development: proof-of-mechanism and proof-of-concept in early phase clinical studies
by: Hemme J. Hijma, MSc, et al.
Published: (2021)

Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy Subjects
by: Michiel J. vanEsdonk, et al.
Published: (2018)

Lack of Detection of the Analgesic Properties of PF‐05089771, a Selective Nav1.7 Inhibitor, Using a Battery of Pain Models in Healthy Subjects
by: Pieter Siebenga, et al.
Published: (2020)

Usos políticos del patrimonio cultural
by: Fabien Van Geert
Published: (2017)

Nontuberculous mycobacterial axillary lymphadenitis in children
by: Jerome A. Lindeboom, et al.
Published: (2021)

A dashboard for the evaluation of the effect of school closures on wellbeing of children and parents
by: Febe Brackx, et al.
Published: (2023)

Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea
by: Sola Han, et al.
Published: (2019)

Dance for Parkinson, multifaceted experiences of persons living with Parkinson's Disease
by: Ingrid Andreasson, et al.
Published: (2024)